Pancreatic cell lines are indispensable in vitro platforms for probing islet biology, exocrine function, and oncogenic pathways in pancreatic ductal adenocarcinoma (PDAC). Among the most frequently employed human pancreatic cancer cell lines are PANC-1, BxPC-3, MIA PaCa-2, AsPC-1, and Capan-1. Each line exhibits unique genetic and phenotypic characteristics: PANC-1 cells (KRAS^G12D mutant) model ductal adenocarcinoma…
In gene therapy and functional genomics, delivery method is as critical as the cargo. Viral vectors—such as lentivirus, adenovirus, and AAV—offer high efficiency and stable integration but come with immunogenicity, cost, and biosafety concerns. Non-viral methods, especially lipid-based transfection reagents like those from Altogen Biosystems, offer rapid, scalable, and low-toxicity alternatives. In pancreatic research, the…
2D monolayer cultures inadequately replicate the tumor microenvironment, prompting a shift toward 3D culture systems like spheroids and organoids. However, transfection efficiency in 3D structures is hampered by diffusion barriers, extracellular matrix components, and hypoxic cores. To overcome these challenges, Altogen’s reagents have been adapted for 3D delivery, employing nano-sized complexes capable of deep tissue…
Studying gene regulation in pancreatic cancer often necessitates co-delivery of functional siRNAs and reporter plasmids. This dual transfection strategy enables simultaneous knockdown of target genes and monitoring of downstream transcriptional activity. Altogen’s high-performance transfection reagents are designed for co-transfection in sensitive lines like Capan-1, BxPC-3, and MIA PaCa-2. By carefully optimizing the reagent-to-DNA:RNA ratio, researchers…
Epithelial-to-mesenchymal transition (EMT) is a hallmark of pancreatic cancer metastasis, conferring invasive potential and therapy resistance. BxPC-3 and PANC-1 cell lines are frequently employed to model EMT due to their epithelial and mesenchymal features, respectively. Transfection-based methods provide a powerful means to study EMT-related genes such as E-cadherin (CDH1), vimentin (VIM), and transcription factors like…
Pancreatic cancer remains one of the most lethal malignancies, with a five-year survival rate that lingers in the single digits. As research accelerates toward targeted therapies and precision medicine, gene manipulation techniques such as knockdown and knockout have become indispensable. But which is more suitable for pancreatic cancer models? Gene knockdown typically involves transient suppression…
Gene therapy is a promising and rapidly evolving field of medical research that aims to treat or prevent diseases by introducing, modifying, or repairing genetic material within a patient’s cells. It offers a potential solution for various genetic disorders, certain types of cancer, and some viral infections. Gene therapy can be broadly categorized into two…
Biopharmaceuticals are a class of therapeutic drugs derived from biological sources, such as living organisms or their components. They include proteins, nucleic acids, and complex carbohydrates, as well as living cells and tissues. Biopharmaceuticals are distinct from traditional small-molecule drugs, which are chemically synthesized. Due to their complex nature and biological origin, biopharmaceuticals often have…
Personalized medicine, also known as precision medicine, is an emerging approach to healthcare that tailors prevention, diagnosis, and treatment strategies to an individual patient’s unique genetic, environmental, and lifestyle factors. Genomics, the study of an organism’s complete set of DNA, plays a crucial role in enabling personalized medicine by providing insights into a person’s genetic…
Hematological toxicity studies are preclinical studies that are conducted to evaluate the potential adverse effects of a substance on the blood and hematopoietic system. These studies are typically conducted in laboratory animals, such as mice, rats, or dogs, to assess the safety of a drug or other substance before testing in humans. The primary objective…
